Research Study

Extension Study of Patidegib Topical Gel, 2% in Subjects With Gorlin Syndrome (Basal Cell Nevus Syndrome)
Principal Investigator 
David Zloty

Overview

Body Locations and Systems 
Skin Conditions
ClinicalTrials.gov# 
NCT04308395
Status 
Recruiting
Study Start/End 
Mar 10, 2021
Name/Title 
Sze Wai Ho, Study Coordinator
Phone 
604-875-5296
Email Address 
SzeWai.Ho@ubc.ca
Purpose of Study 

The purpose of this study is to evaluate the safety and efficacy of Patidegib Topical Gel, 2%, applied topically twice daily to the face of adult subjects with Gorlin syndrome.

Eligibility 

Visit ClinicalTrials.gov for more information.

Disclaimer 

Study Coordinators and Research Nurses cannot give medical advice over the phone. Telephone numbers and email addresses are provided for obtaining additional information on specific research studies only. If you have specific questions which require clinical expertise, please call your primary care physician.